Figure 1From: The proteasomal and apoptotic phenotype determine bortezomib sensitivity of non-small cell lung cancer cellsGrowth inhibition by bortezomib in NSCLC cells. (A) Growth curves (MTT assays) of NSCLC cells treated with different concentrations of bortezomib. Mean of at least three independent experiments, SD. (B) IC50 concentrations and p53 status of individual cell lines. Wt: wild type; mut: mutated.Back to article page